{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:46:12Z","timestamp":1789717572689,"version":"4.0.1"},"reference-count":60,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01358-12, APQ-01008-14, PRONEX APQ-01373-14"],"award-info":[{"award-number":["APQ-01358-12, APQ-01008-14, PRONEX APQ-01373-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["476951\/2013-5"],"award-info":[{"award-number":["476951\/2013-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006675","name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Doen\u00e7as Tropicais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00217","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T12:01:57Z","timestamp":1488801717000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden"],"prefix":"10.3389","volume":"8","author":[{"given":"Bruno Mendes","family":"Roatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Dian de Oliveira","family":"Aguiar-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi Eduardo Soares","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamille Mirelle de Oliveira","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto Siqueira","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory Cristiane Fortes de","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydnei Magno","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelder De Figueiredo","family":"Gontijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney de Almeida","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus G.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Corr\u00eaa-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Cordeiro","family":"Giunchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"issue":"5","key":"B1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B2","author":"W. H. Organization","year":"2011","journal-title":"Eliminating Visceral Leishmaniasis: A Multi-Pronged Approach"},{"issue":"2","key":"B3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/vr.g4378","article-title":"Visceral leishmaniasis: a One Health approach","volume":"175","author":"Vilas","year":"2014","journal-title":"Vet Rec"},{"issue":"949","key":"B4","first-page":"xii","article-title":"Control of the leishmaniasis","volume":"1","author":"World Health Organization","year":"2010","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"11","key":"B5","doi-asserted-by":"publisher","first-page":"e49780","DOI":"10.1371\/journal.pone.0049780","article-title":"Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation","volume":"7","author":"Roatt","year":"2012","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1756-3305-7-61","article-title":"LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4(+) and CD8(+)) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis","volume":"7","author":"Aguiar-Soares","year":"2014","journal-title":"Parasit Vectors"},{"issue":"46","key":"B7","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"B8","doi-asserted-by":"publisher","first-page":"e1000441","DOI":"10.1371\/journal.ppat.1000441","article-title":"Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania","volume":"5","author":"Collin","year":"2009","journal-title":"PLoS Pathog"},{"issue":"26","key":"B9","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trstmh.2009.07.026","article-title":"Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration","volume":"104","author":"Musa","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"B11","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/AAC.00707-15","article-title":": In vivo selection of paromomycin and miltefosine resistance in Leishmania donovani and L. infantum in a Syrian hamster model","volume":"59","author":"Hendrickx","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"8530","key":"B12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"1","author":"Convit","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"B13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0035-9203(03)90093-9","article-title":"Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99","volume":"97","author":"Convit","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"B15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJM199001043220104","article-title":"Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma","volume":"322","author":"Badaro","year":"1990","journal-title":"N Engl J Med"},{"issue":"3","key":"B16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.exppara.2012.05.007","article-title":"Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental visceral leishmaniasis","volume":"131","author":"Shakya","year":"2012","journal-title":"Exp Parasitol"},{"issue":"5","key":"B17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/eji.200324021","article-title":"Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani","volume":"34","author":"Zubairi","year":"2004","journal-title":"Eur J Immunol"},{"issue":"11","key":"B18","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect Immun"},{"issue":"5","key":"B19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1078\/0171-2985-00105","article-title":"Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis","volume":"204","author":"Moll","year":"2001","journal-title":"Immunobiology"},{"issue":"4","key":"B20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.parint.2014.04.002","article-title":"A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study","volume":"63","author":"Joshi","year":"2014","journal-title":"Parasitol Int"},{"issue":"3","key":"B21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.vaccine.2009.09.071","article-title":"Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis","volume":"28","author":"Borja-Cabrera","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"B22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.vaccine.2008.01.026","article-title":"Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis","volume":"26","author":"Miret","year":"2008","journal-title":"Vaccine"},{"issue":"19","key":"B23","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","article-title":"Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE","volume":"28","author":"Trigo","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"B24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.actatropica.2013.04.005","article-title":"Improvement in clinical signs and cellular immunity of dogs with visceral leishmaniasis using the immunomodulator P-MAPA","volume":"127","author":"Santiago","year":"2013","journal-title":"Acta Trop"},{"issue":"7","key":"B25","doi-asserted-by":"publisher","first-page":"e40745","DOI":"10.1371\/journal.pone.0040745","article-title":": Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund\u2019s adjuvant, and monophosphoryl lipid A","volume":"7","author":"Vitoriano-Souza","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.rvsc.2005.09.011","article-title":"Parasite density and impaired biochemical\/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis","volume":"81","author":"Reis","year":"2006","journal-title":"Res Vet Sci"},{"issue":"44","key":"B27","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"B28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.vaccine.2007.11.057","article-title":"A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs","volume":"26","author":"Giunchetti","year":"2008","journal-title":"Vaccine"},{"issue":"31","key":"B29","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1016\/j.vaccine.2008.04.084","article-title":"Kinetics of cell migration to the dermis and hypodermis in dogs vaccinated with antigenic compounds of Leishmania braziliensis plus saponin","volume":"26","author":"Vitoriano-Souza","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"B30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.vetimm.2008.11.030","article-title":"Histological study of cell migration in the dermis of hamsters after immunisation with two different vaccines against visceral leishmaniasis","volume":"128","author":"Moreira","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"B31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.vetpar.2013.09.011","article-title":"Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis","volume":"198","author":"Resende","year":"2013","journal-title":"Vet Parasitol"},{"issue":"2","key":"B32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial","volume":"41","author":"Machado-Pinto","year":"2002","journal-title":"Int J Dermatol"},{"issue":"12","key":"B33","doi-asserted-by":"publisher","first-page":"e82947","DOI":"10.1371\/journal.pone.0082947","article-title":"Clinical forms of canine visceral Leishmaniasis in naturally Leishmania infantum-infected dogs and related myelogram and hemogram changes","volume":"8","author":"Nicolato Rde","year":"2013","journal-title":"PLoS One"},{"issue":"3\u20134","key":"B34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.vetpar.2014.08.022","article-title":"Immunological profile of resistance and susceptibility in naturally infected dogs by Leishmania infantum","volume":"205","author":"de Almeida Leal","year":"2014","journal-title":"Vet Parasitol"},{"issue":"3\u20134","key":"B35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.vetimm.2006.02.001","article-title":"Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi","volume":"112","author":"Reis","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"issue":"6","key":"B36","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/AAC.00208-12","article-title":"Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis","volume":"56","author":"da Silva","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"B37","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.tvjl.2006.11.006","article-title":"Canine visceral leishmaniasis: relationships between clinical status, humoral immune response, haematology and Lutzomyia (Lutzomyia) longipalpis infectivity","volume":"174","author":"da Costa-Val","year":"2007","journal-title":"Vet J"},{"issue":"3","key":"B38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.exppara.2011.08.010","article-title":"Real-time PCR to assess the Leishmania load in Lutzomyia longipalpis sand flies: screening of target genes and assessment of quantitative methods","volume":"129","author":"Bezerra-Vasconcelos","year":"2011","journal-title":"Exp Parasitol"},{"issue":"4","key":"B39","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1128\/CDLI.8.4.828-831.2001","article-title":"Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice","volume":"8","author":"Bretagne","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"B40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1365-2583.2002.00340.x","article-title":"The period gene and genetic differentiation between three Brazilian populations of Lutzomyia longipalpis","volume":"11","author":"Bauzer","year":"2002","journal-title":"Insect Mol Biol"},{"issue":"1","key":"B41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"B42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"5","key":"B43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2217\/imt.09.40","article-title":"Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature","volume":"1","author":"Okwor","year":"2009","journal-title":"Immunotherapy"},{"issue":"2","key":"B44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1590\/S0037-86822010000200016","article-title":"[Mortality due to visceral leishmaniasis: clinical and laboratory characteristics]","volume":"43","author":"Oliveira","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"B45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.clim.2005.06.015","article-title":"T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani","volume":"117","author":"Hailu","year":"2005","journal-title":"Clin Immunol"},{"issue":"17\u201318","key":"B46","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"B47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"issue":"7","key":"B48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.pt.2010.04.005","article-title":"Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis","volume":"26","author":"Reis","year":"2010","journal-title":"Trends Parasitol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2334-5-113","article-title":"Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis","volume":"5","author":"Caldas","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"1\u20132","key":"B50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0304-4017(00)00223-5","article-title":"The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection","volume":"90","author":"Solano-Gallego","year":"2000","journal-title":"Vet Parasitol"},{"issue":"1","key":"B51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0074-02762004000100010","article-title":"Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report","volume":"99","author":"Convit","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"B52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1590\/0037-8682-0022-2012","article-title":"Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis","volume":"46","author":"Bhattacharya","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"issue":"Pt 6","key":"B53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/icb.1993.64","article-title":"Interferon-gamma and interleukin-4 in human Leishmania donovani infections","volume":"71","author":"Kemp","year":"1993","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"B54","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1021\/mp3005098","article-title":"Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis","volume":"10","author":"Duong","year":"2013","journal-title":"Mol Pharm"},{"issue":"4","key":"B55","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.vetimm.2008.11.020","article-title":"Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi","volume":"128","author":"Alves","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"B56","doi-asserted-by":"publisher","first-page":"e0004468","DOI":"10.1371\/journal.pntd.0004468","article-title":"Successful treatment of human visceral leishmaniasis restores antigen-specific IFN-gamma, but not IL-10 production","volume":"10","author":"Adem","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1196\/annals.1428.018","article-title":"Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine","volume":"1149","author":"Manna","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1756-3305-4-52","article-title":"Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments","volume":"4","author":"Miro","year":"2011","journal-title":"Parasit Vectors"},{"issue":"9","key":"B59","doi-asserted-by":"publisher","first-page":"e3136","DOI":"10.1371\/journal.pntd.0003136","article-title":"Visceral leishmaniasis and HIV coinfection in Latin America","volume":"8","author":"Lindoso","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3\u20134","key":"B60","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.vetpar.2006.08.019","article-title":"Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate","volume":"143","author":"Ikeda-Garcia","year":"2007","journal-title":"Vet Parasitol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T11:26:44Z","timestamp":1601724404000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":60,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00217","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]}}}